www.presstrust.com - Avesthagen & CCBR to develop & market nutraceuticals for osteoporosis

Avestha Gengraine Technologies Pvt Ltd, India’s leading biotechnology company today announced a strategic joint venture with the Denmark-based Centre for Clinical & Basic Research (CCBR) and its subsidiary Nordic Biosciences. The companies will work together on a wide array of aspects covering the diagnosis, treatment and prevention of osteoporosis and osteoarthritis.

Avesthagen will be intimately involved with CCBR in putting together a comprehensive platform to develop novel technologies that integrate the diagnosis and treatment of osteoporosis. Osteoporosis is quickly emerging as a leading healthcare problem globally, a situation further exacerbated by the rapidly aging population in developed and developing countries. Through integration of India’s traditions in medicine with advances in biotechnology and medical research, this alliance will enable Avesthagen to rapidly deliver new products to the market as part of its overall strategy for integrating food and pharmaceuticals to diagnose and prevent degenerative diseases. The two companies will also work together to develop the market in India and worldwide for a biomarker-based diagnostic kit that significantly improves on existing technology.

Avesthagen will link its strong competencies in pre-clinical research with CCBR’s extensive experience in clinical research in osteoporosis to develop nutritional bioactive ingredients and new drug leads. Both companies plan to jointly market these products globally.

Addressing the conference, Dr. Villoo M Patell, Founder & CEO, Avestha Gengraine Technologies Pvt Ltd said, “We look forward to our partnership with CCBR. We are confident that this combination of two companies will help improve the current paradigm of osteoporosis care and prevention.”

Speaking at the occasion to announce the tie-up Dr. Claus Christiansen, Founder & CEO, Centre for Clinical & Basic Research said, “We are happy to tie-up with Avesthagen, this partnership will be crucial to jumpstarting the Indo-Danish collaborations in the biotech industry. Our joint venture will address the needs of Osteoporotic patients worldwide.”

About Avesthagen
Avestha Gengraine Technologies is India’s leading fully integrated biotechnology and Bioinformatics Company, focusing on the convergence between food, pharma and clinical genomics leading to preventive personalised medicine. Avesthagen provides innovative solutions for global challenges in agriculture and health problems in the areas of degenerative conditions, metabolic disorders and infectious diseases. The company’s unique and internationally recognized business model is built on the synergetic links between R&D provided and on going initiatives for novel product development.